John Oyler
Director, Chief Executive Officer · 1 filing · Latest: Mar 6, 2026
BeOne Medicines Ltd.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ONC | JOHN V OYLER | — | Dec 15, 2025 | Proposed Sale | $319.06 | 100,000 | $31.9M | — | |
ONC | PAN-OYLER FOUNDATION | — | Sep 16, 2025 | Proposed Sale | $332.27 | 1,204 | $400.1K | — | |
ONC | JOHN V OYLER | — | Sep 16, 2025 | Proposed Sale | $332.27 | 27,803 | $9.2M | — | |
ONC | JOHN V OYLER | — | Jul 9, 2025 | Proposed Sale | $244.47 | 27,802 | $6.8M | — | |
ONC | PAN-OYLER FOUNDATION | — | Jul 8, 2025 | Proposed Sale | $240.99 | 1,661 | $400.3K | — | |
ONC | JOHN OYLER | — | Jun 23, 2025 | Proposed Sale | $261.61 | 3,174 | $830.4K | — | |
ONC | JOHN OYLER | — | Jun 17, 2025 | Proposed Sale | $256.49 | 1,460 | $374.5K | — | |
ONC | JOHN OYLER | — | Jun 16, 2025 | Proposed Sale | $266.05 | 3,680 | $979.0K | — | |
ONC | JOHN OYLER | — | Jun 6, 2025 | Proposed Sale | $252.77 | 5,127 | $1.3M | — | |
ONC | JOHN OYLER | — | Mar 10, 2025 | Proposed Sale | $242.67 | 41,210 | $10.0M | — | Mar 10 9:51 PM 144/A |
ONC | JOHN OYLER | — | Mar 10, 2025 | Proposed Sale | $242.67 | 41,210 | $10.0M | — | |
ONC | JOHN OYLER | — | Mar 7, 2025 | Proposed Sale | $249.13 | 58,590 | $14.6M | — | |
ONC | JOHN OYLER | — | Mar 6, 2025 | Proposed Sale | $259.15 | 40,109 | $10.4M | — | |
ONC | JOHN OYLER | — | Mar 3, 2025 | Proposed Sale | $244.30 | 101,000 | $24.7M | — | |
ONC | PAN-OYLER FOUNDATION | — | Nov 25, 2024 | Proposed Sale | $190.51 | 1,969 | $375.1K | — | |
ONC | JOHN F OYLER | — | Oct 8, 2024 | Proposed Sale | $243.02 | 6,175 | $1.5M | — | |
ONC | OYLER INVESTMENT LLC | — | Oct 8, 2024 | Proposed Sale | $243.02 | 10,000 | $2.4M | — | |
ONC | PAN-OYLER FOUNDATION | — | Aug 27, 2024 | Proposed Sale | $199.22 | 1,883 | $375.1K | — |